# Treatment of Pregnancy RA

> **NCT04569890** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Pregnancy Related

## Interventions

- **DRUG:** Certolizumab Pegol 200 MG/ML [Cimzia]
- **DRUG:** Hydroxychloroquine
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT04569890
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04569890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04569890, "Treatment of Pregnancy RA". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04569890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*